Literature DB >> 15578524

Assessing fibrosis without a liver biopsy: are we there yet?

D Montgomery Bissell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15578524     DOI： 10.1053/j.gastro.2004.10.012

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

Review 1.  An appraisal of the histopathological assessment of liver fibrosis.

Authors:  R A Standish; E Cholongitas; A Dhillon; A K Burroughs; A P Dhillon
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

2.  Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.

Authors:  Amy G Shah; Paula G Smith; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2011-04-28       Impact factor: 3.199

3.  Arg-gly-asp-mannose-6-phosphate inhibits activation and proliferation of hepatic stellate cells in vitro.

Authors:  Lian-Sheng Wang; Ying-Wei Chen; Ding-Guo Li; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

4.  Assessing liver fibrosis with serum marker models.

Authors:  Enrico Rossi; Leon A Adams; Max Bulsara; Gary P Jeffrey
Journal:  Clin Biochem Rev       Date:  2007-02

5.  Estimating complex multi-state misclassification rates for biopsy-measured liver fibrosis in patients with hepatitis C.

Authors:  Peter Bacchetti; Ross Boylan
Journal:  Int J Biostat       Date:  2009       Impact factor: 0.968

6.  A secreted form of the asialoglycoprotein receptor, sH2a, as a novel potential noninvasive marker for liver fibrosis.

Authors:  Elena Veselkin; Maria Kondratyev; Yoav Lurie; Efrat Ron; Moshe Santo; Shimon Reif; Irma Elashvili; Lana Bar; Gerardo Z Lederkremer
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

7.  Serum N-terminal DDR1: A Novel Diagnostic Marker of Liver Fibrosis Severity.

Authors:  Yuxin Zhang; Yujie Zhang; Huifang Liang; Zeng Zhuo; Pan Fan; Yifa Chen; Zhanguo Zhang; Wanguang Zhang
Journal:  J Clin Transl Hepatol       Date:  2021-04-25

8.  Meta-analyses of FibroTest diagnostic value in chronic liver disease.

Authors:  Thierry Poynard; Rachel Morra; Philippe Halfon; Laurent Castera; Vlad Ratziu; Françoise Imbert-Bismut; Sylvie Naveau; Dominique Thabut; Didier Lebrec; Fabien Zoulim; Marc Bourliere; Patrice Cacoub; Djamila Messous; Mona Munteanu; Victor de Ledinghen
Journal:  BMC Gastroenterol       Date:  2007-10-15       Impact factor: 3.067

9.  Staging of rat liver fibrosis using monoexponential, stretched exponential and diffusion kurtosis models with diffusion weighted imaging- magnetic resonance.

Authors:  Genwen Hu; Wen Liang; Mingxiang Wu; Queenie Chan; Yufa Li; Jianmin Xu; Liangping Luo; Xianyue Quan
Journal:  Oncotarget       Date:  2017-12-18

10.  Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.

Authors:  Gabriel Perlemuter; Patrice Cacoub; Dominique Valla; Dominique Guyader; Barbara Saba; Cécile Batailler; Kevin Moore
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.